当前位置:
X-MOL 学术
›
J. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Transitions in the nomenclatures for fatty liver disease
Journal of Hepatology ( IF 26.8 ) Pub Date : 2024-12-17 , DOI: 10.1016/j.jhep.2024.12.019 Maito Suoh, Saeed Esmaili, Mohammed Eslam, Jacob George
中文翻译:
脂肪肝疾病命名法的转变
构思、数据收集和手稿起草由 MS 和 ME 进行。所有作者都严格审查、修改和批准了最终手稿。
用于分析的 R 代码存放在 GitHub (https://github.com/maitosuoh/fatty-liver-time-series) 中。
SE、ME 和 JG 得到了悉尼大学悉尼医学基金会 Robert W. Storr 遗赠的支持;澳大利亚国家健康与医学研究委员会 (NHMRC) 计划拨款 (APP1053206)、项目、想法和研究者拨款(APP2001692、GNT1107178、GNT1108422、GNT1196492、GNT2008983)和新南威尔士州癌症研究所拨款 (2021/ATRG2028)。
作者声明他们没有利益冲突。有关更多详细信息,请参阅随附的 ICMJE 披露表。
更新日期:2024-12-18
Journal of Hepatology ( IF 26.8 ) Pub Date : 2024-12-17 , DOI: 10.1016/j.jhep.2024.12.019 Maito Suoh, Saeed Esmaili, Mohammed Eslam, Jacob George
Section snippets
Clinical trial number:
Not applicable.Authors’ contributions
The conception, data collection, and drafting the manuscript were performed by MS and ME. All authors critically reviewed, revised, and approved the final manuscript.Data availability statement
The R code for the analysis was deposited in GitHub (https://github.com/maitosuoh/fatty-liver-time-series).Financial support
SE, ME, and JG are supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, The University of Sydney; a National Health and Medical Research Council of Australia (NHMRC) Program Grant (APP1053206), Project, Ideas and Investigator Grants (APP2001692, GNT1107178, GNT1108422, GNT1196492, GNT2008983) and a Cancer Institute, NSW grant (2021/ATRG2028).Declaration of Competing Interest
The authors declare that they have no conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details.Acknowledgements
Not applicable.中文翻译:
脂肪肝疾病命名法的转变
部分片段
临床试验编号:
不適用。作者的贡献
构思、数据收集和手稿起草由 MS 和 ME 进行。所有作者都严格审查、修改和批准了最终手稿。
数据可用性声明
用于分析的 R 代码存放在 GitHub (https://github.com/maitosuoh/fatty-liver-time-series) 中。
财务支持
SE、ME 和 JG 得到了悉尼大学悉尼医学基金会 Robert W. Storr 遗赠的支持;澳大利亚国家健康与医学研究委员会 (NHMRC) 计划拨款 (APP1053206)、项目、想法和研究者拨款(APP2001692、GNT1107178、GNT1108422、GNT1196492、GNT2008983)和新南威尔士州癌症研究所拨款 (2021/ATRG2028)。
利益争夺声明
作者声明他们没有利益冲突。有关更多详细信息,请参阅随附的 ICMJE 披露表。